Kembali
KLBF - Kalbe Farma

KLBF – In collaboration with Dr.Moewardi Hospital for cell therapy services

11 Juli 2024

KLBF – In collaboration with Dr.Moewardi Hospital for cell therapy services Kalbe Farma (KLBF) collaborates with Dr. Moewardi Hospital in Solo in developing cell therapy services and its products, such as stem cells, secretomes and exosomes, through Regenic Stem Cell which is a production facility owned by KLBF's subsidiary, Bifarma Adiluhung (BFA). Note that, the facilities at DR. Moewardi was inaugurated on July 11, 2023 and is in the process of obtaining an operational license as a stem cell processing laboratory and Good Manufacturing Practice certification. Therefore, Dr. Moewardi Hospital collaborated with BFA to obtain the certification. (Source : Kontan)

Related Research

Consumer
KLBF - Stronger growth and margins expansion
Andre Suntono 12 Juli 2023 Lihat Detail
Consumer
KLBF - Expects a Brighter 24F, after a weak 23f
Andre Suntono 20 Maret 2024 Lihat Detail
Healthcare
KLBF - Further growth in ‘25F on better product mix and costs ma...
Andre Suntono 13 Juni 2025 Lihat Detail